Log in to save to my catalogue

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carc...

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c7f86cdcb25043d29d5876749e8c0149

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

About this item

Full title

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2019-04, Vol.19 (1), p.366-366, Article 366

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is.

Alternative Titles

Full title

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c7f86cdcb25043d29d5876749e8c0149

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c7f86cdcb25043d29d5876749e8c0149

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-019-5568-6

How to access this item